SkinBioTherapeutics (SBTX) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 Aug 2019 02:00 PM
RNS
Price Monitoring Extension
28 Aug 2019 07:00 AM
RNS
Holding(s) in Company
04 Jul 2019 07:00 AM
RNS
Business Update and Board Changes
18 Apr 2019 07:00 AM
RNS
Director Appointment
16 Apr 2019 07:00 AM
RNS
Director/PDMR Shareholding
08 Apr 2019 07:00 AM
RNS
SkinBiotix shows efficacy in first human study
29 Mar 2019 07:00 AM
RNS
CEO Designate Appointment
18 Feb 2019 07:00 AM
RNS
Issue of Equity
14 Feb 2019 07:00 AM
RNS
Half year results
01 Feb 2019 03:30 PM
RNS
Appointment of Joint Broker
31 Jan 2019 08:35 AM
RNS
Update on human study and IP portfolio extension
31 Jan 2019 07:00 AM
RNS
Update on human studies & IP portfolio extension
20 Nov 2018 07:00 AM
RNS
Commencement of final phase of human studies
19 Nov 2018 12:30 PM
RNS
Result of AGM
07 Nov 2018 07:00 AM
RNS
SkinBiotix® generates positive data in human study
25 Oct 2018 07:00 AM
RNS
Full year results
19 Sep 2018 07:00 AM
RNS
Human study commenced
18 Sep 2018 02:05 PM
RNS
Second Price Monitoring Extn
18 Sep 2018 02:00 PM
RNS
Price Monitoring Extension
03 Sep 2018 07:00 AM
RNS
SkinBiotix technology successful in stability test
16 Aug 2018 11:05 AM
RNS
Second Price Monitoring Extn
16 Aug 2018 11:00 AM
RNS
Price Monitoring Extension
16 Aug 2018 07:00 AM
RNS
Business Update
03 Aug 2018 08:57 AM
RNS
Holding(s) in Company
23 Jul 2018 01:13 PM
RNS
Holding(s) in Company
18 Jul 2018 07:00 AM
RNS
Provisional ethics approval for human study
29 May 2018 07:00 AM
RNS
SkinBioTherapeutics involved in new research grant
14 May 2018 07:00 AM
RNS
SkinBioTherapeutics files new patent application
01 May 2018 07:00 AM
RNS
SkinBioTherapeutics plans for human study
24 Apr 2018 08:56 AM
RNS
Holding(s) in Company
17 Apr 2018 07:00 AM
RNS
Positive cream formulation results for SkinBiotix
03 Apr 2018 07:00 AM
RNS
SBTX signs MTA with global consumer goods company
21 Feb 2018 07:00 AM
RNS
Half year results
16 Feb 2018 10:02 AM
RNS
Notice of Interim Results
05 Jan 2018 07:00 AM
RNS
Appointment of Joint Broker
01 Dec 2017 07:05 AM
RNS
Notification of first patent grant
09 Nov 2017 07:00 AM
RNS
SkinBiotix platform passes external toxicity tests
08 Nov 2017 11:32 AM
RNS
SkinBioTherapeutics to present at investor evening
30 Oct 2017 11:23 AM
RNS
Result of AGM
05 Oct 2017 07:00 AM
RNS
Final Results
03 Oct 2017 07:00 AM
RNS
Cytotoxicity results and scientific update
27 Sep 2017 09:00 AM
RNS
Notice of Results
12 Sep 2017 08:54 AM
RNS
Holding(s) in Company
19 Jun 2017 09:00 AM
RNS
SkinBioTherapeutics to Present at Investor Evening
09 Jun 2017 10:38 AM
RNS
Holding(s) in Company
23 May 2017 03:21 PM
RNS
Holding(s) in Company
23 May 2017 07:00 AM
RNS
Extension of Research Contract
05 Apr 2017 07:00 AM
RNS
First day of dealings - to trade under SBTX ticker

SkinBioTherapeutics is a life science company that develops technologies to improve health by harnessing the human microbiome.

SkinBioTherapeutics is based in Newcastle upon Tyne, United Kingdom.

SkinBioTherapeutics is listed in London under the ticker SBTX.

SBTX share price listed at 16p in 2017.

UK 100